The biological basis of malarial disease

International Journal for Parasitology

Volumn 27, Issue 10, 1997, Pages 1237-1249

  Clark, Ian A ^a   Al Yaman, Fadwa M ^a   Jacobson, Linda S ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Cerebral malaria; Creatinine; Cytokine; Glucose; Interleukin 1; Lactate; Malaria; Malaria tolerance; Nitric oxide; Tumour necrosis factor

Indexed keywords

NITRIC OXIDE;

BRAIN MALARIA; CONFERENCE PAPER; FATALITY; GLUCONEOGENESIS; HUMAN; HYPOGLYCEMIA; HYPOXIA; MALARIA; MALARIA FALCIPARUM; NONHUMAN;

EID: 0342684539     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-7519(97)00121-5     Document Type: Conference Paper

References (141)

1. Ahmad S. H., Danish T., Faridi M. M., Ahmad A. J., Fakhir S. & Khan A. S. 1989. Renal function in acute malaria in children. Journal of Tropical Pediatrics 35: 291-294.
2. Ahvazi B. C., Jacobs P. & Stevenson M. M. 1995. Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria. Journal of Leukocyte Biology 58: 23-31.
3. Al Yaman F., Genton B., Mokela D., Rockett K. A., Alpers M. P., & Clark I. A. 1996. Association between serum levels of reactive nitrogen intermediates and coma in children with cerebral malaria in Papua New Guinea. Transactions of the Royal Society of Tropical Medicine and Hygiene 90: 270-273.
4. Al Yaman F., Awburn M. M. & Clark I. A. 1997. Serum creatinine levels and reactive nitrogen intermediates in children with cerebral malaria in Papua New Guinea. Transactions of the Royal Society of Tropical Medicine & Hygiene 91: 303-305.
5. Andrykowski M. A., Schmitt F. A., Gregg M. E., Brady M. J., Lamb D. G. & Hensleedowney P. J. 1992. Neuropsychologic impairment in adult bone marrow transplant candidates. Cancer 70: 2288-2297.
6. Anonymous 1942. Memorandum 24 on medical diseases in tropical and sub-tropical areas, The War Office, London. McLaren, Melbourne.
7. Anstey N. M., Weinberg J. B., Hassanali M. Y., Mwaikambo E. D., Manyenga D., Misukonis M. A., Arnelle D. R., Hollis D., McDonald M. I. & Granger D. L. 1996. Nitric oxide in Tanzanian children with malaria. Journal of Experimental Medicine 184: 557-567.
8. Aronstam R. S., Martin D. C. & Dennison R. L. 1994. Volatile anesthetics inhibit NMDA-stimulated 45Ca uptake by rat brain microvesicles. Neurochemical Research 19: 1515-1520.
9. Bate C. A. W., Taverne J., Dave A. & Playfair J. H. L. 1990. Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. Immunology 70: 315-320.
10. Bate C. A. W., Taverne J. & Playfair J. H. L. 1988. Malarial parasites induce TNF production by macrophages. Immunology 64: 227-231.
11. Berendt A. R., Turner G. D. H. & Newbold C. I. 1994. Cerebral malaria: the sequestration hypothesis. Parasitology Today 10: 412-414.
12. Bianchi M., Battistin T. & Galzigna L. 1991. 2,6-diisopropylphenol, a general anesthetic, inhibits glutamate action on rat synaptosomes. Neurochemical Research 16: 443-446.
13. Bird T. A., Davies A., Baldwin S. A. & Saklatvala J. 1990. Interleukin-1 stimulates hexose transport in fibroblasts by increasing the expression of glucose transporters. Journal of Biological Chemistry 265: 13578-13583.
14. Bohme G. A., Bon C., Lemaire M., Reibaud M., Piot O., Stutzmann J. M., Doble A. & Blanchard J. C. 1993. Altered synaptic plasticity and memory formation in nitric oxide synthase inhibitor-treated rats. Proceedings of the National Academy of Science USA 90: 9191-9194.
15. Bone R. C. 1992. Abnormal cellular metabolism in sepsis. A new interpretation. The Journal of the American Medical Association 267: 1518-1519.
16. Bouchama A., Alsedairy S., Siddiqui S., Shail E. & Rezeig M. 1993. Elevated pyrogenic cytokines in heatstroke. Chest 104: 1498-1502.
17. Brooks G. A. 1991. Current concepts in lactate exchange. Medicine and Science in Sports and Exercise 23: 895-906.
18. Butcher G. A., Garland T., Adjukiewicz A. B. & Clark I. A. 1990. Serum TNF associated with malaria in patients in the Solomon Islands. Transactions of the Royal Society of Tropical Medicine and Hygiene 85: 658-661.
19. Campbell I. L., Samimi A. & Chiang C. S. 1994. Expression of the inducible nitric oxide synthase - correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. Journal of Immunology 153: 3622-3629.
20. Carla V. & Moroni F. 1992. General anaesthetics inhibit the responses induced by glutamate receptor agonists in the mouse cortex. Neuroscience Letters 146: 21-24.
21. Chatenoud L. 1993. OKT3-induced cytokine-release syndrome - preventive effect of anti-tumor necrosis factor monoclonal antibody. Transplantation Proceedings 25: 47-51.
22. Clark I. A. 1978. Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet ii: 75-77.
23. Clark I. A. 1982. Suggested importance of monokines in pathophysiology of endotoxin shock and malaria. Klinische Wochenschrift 60: 756-758.
24. Clark I. A. 1987. Cell-mediated immunity in protection and pathology of malaria. Parasitology Today 3: 300-305.
25. Clark I. A., Al Yaman F. M., Cowden W. B. & Rockett K. A. 1996. Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa. Lancet 348: 1492-1494.
26. Clark I. A., Chaudhri G. & Cowden W. B. 1989. Roles of tumour necrosis factor in the illness and pathology of malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 83: 436-440.
27. Clark I. A. & Cowden W. B. 1991. Roles of TNF in malaria and other parasitic infections. In: Tumor Necrosis Factors; Structures, Functions and Mechanisms of Action. (Edited by Aggarwal B. B. & Vilcek J.), pp. 365-407. Marcel Dekker, New York.
28. Clark I. A., Cowden W. B., Butcher G. A. & Hunt N. H. 1987. Possible roles of tumor necrosis factor in the pathology of malaria. American Journal of Pathology 129: 192-199.
29. Clark I. A., & Rockett K. A. 1996. Nitric oxide and parasitic disease. In: Advances in Parasitology, Vol 37. (Edited by Baker J. R., Muller R. and Rollinson D.), pp. 1-56.
30. Clark I. A., Rockett K. A. & Cowden W. B. 1991. Proposed link between cytokines, nitric oxide, and human cerebral malaria. Parasitology Today 7: 205-207.
31. Clark I. A., Rockett K. A. & Cowden W. B. 1992. Possible central role of nitric oxide in conditions clinically similar to cerebral malaria. Lancet 340: 894-896.
32. Clark I. A., Virelizier J.-L., Carswell E. A. & Wood P. R. 1981. Possible importance of macrophage-derived mediators in acute malaria. Infection and Immunity 32: 1058-1066.
33. Cot S., Ringwald P., Mulder B., Miailhes P., Yapyap J., Nussler A. K. & Eling W. M. C. 1994. Nitric oxide in cerebral malaria. Journal of Infectious Diseases 169: 1417-1418.
34. Curtis S. E. & Cain S. M. 1992. Regional and systemic oxygen delivery/uptake relations and lactate flux in hyperdynamic, endotoxin-treated dogs. American Review of Respiratory Diseases 145: 348-354.
35. Daniel H., Hemart N., Jaillard D. & Crepel F. 1993. Long-term depression requires nitric oxide and guanosine 3':5' cyclic monophosphate production in rat cerebellar purkinje cells. European Journal of Neuroscience 5: 1079-1082.
36. Darville T. & Giroir B., Jacobs R. 1993. The systemic inflammatory response syndrome (SIRS) - immunology and potential immunotherapy. Infection 21: 279-290.
37. Davis T. M. E., Looareesuwan S., Pukrittayakamee S., Levy J. C., Nagachinta B. & White N. J. 1993. Glucose turnover in severe falciparum malaria. Metabolism - Clinical and Experimental 42: 334-340.
38. Davis T. M. E., Pukrittayakamee S., Supanaranond W., Looareesuwan S., Krishna S., Nagachinta B., Turner R. C. & White N. J. 1990. Glucose metabolism in quinine-treated patients with uncomplicated falciparum malaria. Clinical Endocrinology 33: 739-749.
39. Denicoff K. D., Rubinow D. R., Papa M. Z., Simpson C., Seipp C. A., Lotze M. T., Chang A. E., Rosenstein D. & Rosenberg S. A. 1987. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Annals of Internal Medicine 107: 293-300.
40. Denis M. 1994. Human monocytes/macrophages: NO or no NO? Journal of Leukocyte Biology 55: 682-684.
41. Dirnagl U., Lindauer U. & Villringer A. 1993. Role of nitric oxide in the coupling of cerebral blood flow to neuronal activation in rats. Neuroscience Letters 149: 43-46.
42. Elased K., Desouza J. B. & Playfair J. H. L. 1995. Blood-stage malaria infection in diabetic mice. Clinical and Experimental Immunology 99: 440-444.
43. Elased K. & Playfair J. H. L. 1994. Hypoglycemia and hyperinsulinemia in rodent models of severe malaria infection. Infection and Immunity 62: 5157-5160.
44. Elased K. M. & Playfair J. H. L. 1996. Reversal of hypoglycaemia in murine malaria by drugs that inhibit insulin secretion. Parasitology 112: 515-521.
45. Evans D. A., Jacobs D. O. & Wilmore D. W. 1989. Tumor necrosis factor enhances glucose uptake by peripheral tissues. American Journal of Physiology 257: R1182-R1189.
46. Fahmi H., Ancuta P., Perrier S. & Chaby R. 1996. Pre-exposure of mouse peritoneal macrophages to lipopolysaccharide and other stimuli enhances the nitric oxide response to secondary stimuli. Inflammation Research 45: 347-353.
47. Fahmi H., Charon D., Mondange M. & Chaby R. 1995. Endotoxin-induced desensitization of mouse macrophages is mediated in part by nitric oxide production. Infection and Immunity 63: 1863-1869.
48. Feinstein R., Kanety H., Papa M. Z., Lunenfeld B. & Karasik A. 1993. Tumor necrosis factor-alpha suppresses Insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. Journal of Biological Chemistry 268: 26055-26058.
49. Fukuzumi M., Shinomiya H., Shimizu Y., Ohishi F. & Utsumi S. 1996. Endotoxin-induced enhancement of glucose influx into murine peritoneal macrophages via GLUT1. Infection and Immunity 64: 108-112.
50. 13C nuclear magnetic resonance. Experimental Parasitology 59: 364-374.
51. Ghigo D., Todde R., Ginsburg H., Costamagna C., Gautret P., Bussolino F., Ulliers D., Giribaldi G., Deharo E., Gabrielli G., Pescarmona G. & Bosia A. 1995. Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS-inducing soluble factor. Journal of Experimental Medicine 182: 677-688.
52. Gilbert V. E. 1968. Blood pyruvate and lactate during febrile human infections. Metabolism 17: 943-951.
53. Gore D. C., Jahoor F., Hibbert J. M. & Demaria E. J. 1996. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Annals of Surgery 224: 97-102.
54. Grau G. E., Piquet P.-F., Vassalli P. & Lambert P.-H. 1989a. Tumor necrosis factor and other cytokines in cerebral malaria. Experimental and clinical data. Immunology Reviews 112: 49-70.
55. Grau G. E., Taylor T. E., Molyneux M. E., Wirima J. J., Vassalli P., Hommel M. & Lambert P.-H. 1989b. Tumor necrosis factor and disease severity in children with falciparum malaria. New England Journal of Medicine 320: 1586-1591.
56. Greenwood B. M., Bradley-Moore A. M., Palit A. & Bryceson A. D. M. 1972. Immunosuppression in children with malaria. Lancet i: 169-172.
57. Hauner H., Petruschke T., Russ M., Rohrig K. & Eckel J. 1995. Effects of tumour necrosis factor alpha (TNF alpha) on glucose transport and lipid metabolism of newly-differentiated human fat cells in cell culture. Diabetologia 38: 764-771.
58. Hayano Y. 1991. Influence of induced hyperthermia on intestinal blood flow, translocation of endotoxin and other factors in mongrel dogs. Masui 40: 769-781.
59. Heyman A. & Beeson P. B. 1949. Influence of various disease states upon the febrile response to intravenous injection of typhoid bacterial pyrogen. Journal of Laboratory and Clinical Medicine 34: 1400-1403.
60. Hooper D. C., Ohnishi S. T., Kean R., Numagami Y., Dietzschold B. & Koprowski H. 1995. Local nitric oxide production in viral and autoimmune diseases of the central nervous system. Proceedings of the National Academy of Science USA 92: 5312-5316.
61. Hotchkiss R. S. & Karl I. E. 1992. Reevaluation of the role of cellular hypoxia and bioenergetic failure in sepsis. The Journal of the American Medical Association 267: 1503-1510.
62. Hotchkiss R. S., Rust R. S., Dence C. S., Wasserman T. H., Song S. K., Hwang D. R., Karl I. E. & Welch M. J. 1991. Evaluation of the role of cellular hypoxia in sepsis by the hypoxic marker [18F]fluoromisonidazole. American Journal of Physiology 261: R965-R972.
63. Iadecola C. 1993. Regulation of the cerebral microcirculation during neural activity - is nitric oxide the missing link. Trends in Neurosciences 16: 206-214.
64. Kapas L., Fang J. D. & Krueger J. M. 1994a. Inhibition of nitric oxide synthesis inhibits rat sleep. Brain Research 664: 189-196.
65. Kapas L., Shibata M., Kimura M. & Krueger J. M. 1994b. Inhibition of nitric oxide synthesis suppresses sleep in rabbits. American Journal of Physiology 266: R151-R157.
66. Kern P., Hemmer C. J., Van Damme J., Gruss H.-J. & Dietrich M. 1989. Elevated tumour necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria. American Journal of Medicine 87: 139-143.
67. Kitchen S. F. 1949. Falciparum malaria. In: Malariology. (Edited by Boyd M. F.), pp. 966-994. W. B. Saunders, Philadelphia.
68. Kolb J. P., Pauleugene N., Damais C., Yamaoka K., Drapier J. C. & Dugas B. 1994. Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes - involvement of the nitric oxide synthase pathway. Journal of Biological Chemistry 269: 9811-9816.
69. Kremsner P. G., Winkler S., Wildling E., Prada J., Bienzle U., Graninger W. & Nussler A. K. 1996. High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in plasmodium falciparum malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene 90: 44-47.
70. Krishna S., Agbenyega T., Angus B. J., Beduaddo G., Oforiamanfo G., Henderson G., Szwandt I. S. F., Obrien R. & Stacpoole P. W. 1995. Pharmacokinetics and pharmacodynamics of dichloroacetate in children with lactic acidosis due to severe malaria. Quarterly Journal of Medicine 88: 341-349.
71. Krishna S., Waller D. W., Terkuile F., Kwiatkowski D., Crawley J., Craddock C. F. C., Nosten F., Chapman D., Brewster D., Holloway P. A. & White N. J. 1994. Lactic acidosis and hypoglycaemia in children with severe malaria - pathophysiological and prognostic significance. Transactions of the Royal Society of Tropical Medicine and Hygiene 88: 67-73.
72. Krueger J. M., Takahashi S., Kapas L., Bredow S., Roky R., Fang J. D., Floyd R., Renegar K. B., Guhathakurta N., Novitsky S. & Obal F. 1995. Cytokines in sleep regulation. Advances in Neuroimmunology 5: 171-188.
73. Kwiatkowski D., Hill A. V. S., Sambou I., Twumasi P., Castracane J., Manogue K. R., Cerami A., Brewster D. R. & Greenwood B. M. 1990. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336: 1201-1204.
74. Kwiatkowski D., Molyneux M. E., Stephens S., Curtis N., Klein N., Pointaire P., Smit M., Allan R., Brewster D. R., Grau G. E. & Greenwood B. M. 1993. Anti-TNF therapy inhibits fever in cerebral malaria. Quarterly Journal of Medicine 86: 91-98.
75. Lander H. M., Sehajpal P., Levine D. M. & Novogrodsky A. 1993a. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. Journal of Immunology 150: 1509-1516.
76. Lander H. M., Sehajpal P. K. & Novogrodsky A. 1993b. Nitric oxide signaling: a possible role for G proteins. Journal of Immunology 151: 7182-7187.
77. Lang C. H. & Dobrescu C. 1991. Sepsis-induced increases in glucose uptake by macrophage-rich tissues persist during hypoglycemia. Metabolism 40: 585-593.
78. Lang C. H., Dobrescu C. & Bagby G. J. 1992. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 130: 43-52.
79. Lee M. D., Zentella A., Vine W., Pekala P. H., & Cerami A. 1987. Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6. Proceedings of the National Academy of Science USA 84: 2590-2594.
80. Lei S. Z., Pan Z. H., Aggarwal S. K., Chen H. S. V., Hartman J., Sucher N. J. & Lipton S. A. 1992. Effect of nitric oxide production on the redox modulatory site of the NMDA receptor-channel complex. Neuron 8: 1087-1099.
81. Lepoivre M., Fieschi F., Coves J., Thelander L. & Fontecave M. 1991. Inactivation of ribonucleotide reductase by nitric oxide. Biochemical and Biophysical Research Communications 179: 442-448.
82. Looareesuwan S., Wilairatana P., Krishna S., Kendall B., Vannaphan S., Viravan C. & White N. J. 1995. Magnetic resonance imaging of the brain in patients with cerebral malaria. Clinical Infectious Diseases 21: 300-309.
83. Lovinger D. M., White G. & Weight F. F. 1989. Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243: 1721-1724.
84. MacPherson G. G., Warrell M. J., White N. J., Looareesuwan S. & Warrell D. A. 1985. Human cerebral malaria. A quantitative ultrastructural analysis of parasitised erythrocyte sequestration. American Journal of Pathology 119: 385-401.
85. Manzoni O., Prezeau L., Marin P., Deshager S., Bockaert J. & Fagni L. 1992. Nitric oxide-induced blockade of NMDA receptors. Neuron 8: 653-662.
86. McGowan K. M., Long S. D. & Pekala P. H. 1995. Glucose transporter gene expression: regulation of transcription and mRNA stability. Pharmacology and Therapeutics 66: 465-505.
87. McGuire W., Hill A. V. S., Allsopp C. E. M., Greenwood B. M. & Kwiatkowski D. 1994. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-511.
88. Merrill J. E., Koyanagi Y., Zack J., Thomas L., Martin F. & Chen I. S. Y. 1992. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type-1. Journal of Virology 66: 2217-2225.
89. Meszaros K., Lang C. H., Bagby G. J. & Spitzer J. J. 1987. Tumor necrosis factor increases in vivo glucose utilization of macrophage-rich tissues. Biochemical and Biophysical Research Communications 149: 1-6.
90. Mills C. D. 1991. Molecular basis of "suppressor" macrophages: arginine metabolism via the nitric oxide synthetase pathway. Journal of Immunology 146: 2719-2723.
91. Mizock B. A. 1995. Alterations in carbohydrate metabolism during stress: a review of the literature. American Journal of Medicine 98: 75-84.
92. Molyneux M. E., Looareesuwan S., Menzies I. S., Grainger S. L., Phillips R. E., Wattanagoon Y., Thompson R. P. & Warrell D. A. 1989a. Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. American Journal of Tropical Medicine and Hygiene 40: 470-476.
93. Molyneux M. E., Taylor T. E., Wirima J. J. & Borgstein A. 1989b. Clinical features and prognostic indicators in paediatric malaria: A study of 131 comatose Malawian children. Quarterly Journal of Medicine 71: 441-459.
94. Montague P. R., Gancayco C. D., Winn M. J., Marchase R. B. & Friedlander M. J. 1994. Role of NO production in NMDA Receptor-Mediated neurotransmitter release in cerebral cortex. Science 263: 973-977.
95. Moore R. N., Goodrum K. J., Couch R. & Berry L. J. 1978. Factors affecting macrophage function: glucocorticicoid antagonizing factor. Journal of the Reticuloendothelial Society 23: 321-332.
96. Murray H. W. & Teitelbaum R. F. 1992. L-arginine dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. Journal of Infectious Diseases 165: 513-517.
97. Musleh W. Y., Shahi K. & Baudry M. 1993. Further studies concerning the role of nitric oxide in LTP induction and maintenance. Synapse 13: 370-375.
98. Newton C. R. J. C., Kirkham F. J., Winstanley P. A., Pasvol G., Peshu N., Warrell D. A. & Marsh K. 1991. Intracranial pressure in African children with cerebral malaria. Lancet 337: 573-576.
99. Northington F. J., Matherne G. P., & Berne R. M. 1992. Competitive inhibition of nitric oxide synthase prevents the cortical hyperemia associated with peripheral nerve stimulation. Proceedings of the National Academy of Science USA 89: 6649-6652.
100. Nussler A. K., Eling W. & Kremsner P. G. 1994. Patients with Plasmodium falciparum malaria and Plasmodium vivax malaria show increased nitrite and nitrate plasma levels. Journal of Infectious Diseases 169: 1418-1419.
101. Osuntokun B. O., Bademosi O., Ogunremi K. & Wright S. G. 1972. Neuropsychiatric manifestations of typhoid fever in 959 patients. Archives of Neurology 27: 7-13.
102. Petit F., Bagby G. J. & Lang C. H. 1995. Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance. American Journal of Physiology 268: E219-E228.
103. Phillips R. E. 1989. Hypoglycaemia is an important complication of falciparum malaria. Quarterly Journal of Medicine 71: 477-483.
104. Phillips R. E., Looareesuwan S., Molyneux M. E., Hatz C. & Warrell D. A. 1993. Hypoglycaemia and counterregulatory hormone responses in severe falciparum malaria-treatment with sandostatin. Quarterly Journal of Medicine 86: 233-240.
105. Puil E., El-Beheiry H. & Baimbridge K. G. 1990. Anaesthetic effects on glutamate-stimulated increase in intraneuronal calcium. Journal of Pharmacology and Experimental Therapeutics 255: 955-961.
106. Pukrittayakamee S., White N. J., Davis T. M. E., Looareesuwan S., Supanaranond W., Desakorn V., Chaivisuth B. & Williamson D. H. 1992. Hepatic blood flow and metabolism in severe falciparum malaria: clearance of intravenously administered galactose. Clinical Science 82: 63-70.
107. Raymond R. M., McLane M. P., Law W. R., King N. F. & Leutz D. W. 1988. Myocardial insulin resistance during acute endotoxin shock in dogs. Diabetes 37: 1684-1688.
108. Rockett K. A., Awburn M. M., Rockett E. J., Cowden W. B. & Clark I. A. 1994. Possible role of nitric oxide in malarial immunosuppression. Parasite Immunology 16: 243-249.
109. Rockett K. A., Kwiatkowski D., Bate C. A. W., Awburn M. M., Rockett E. J. & Clark I. A. 1996. In vitro induction of nitric oxide by an extract of Plasmodium falciparum. Journal of Infection 32: 187-196.
110. Rojas A., Padron J., Caveda L., Palacios M. & Moncada S. 1993. Role of nitric oxide pathway in the protection against lethal endotoxemia afforded by low doses of lipopolysaccharide. Biochemical and Biophysical Research Communications 191: 441-446.
111. Rubenstein M., Mulholland J. H., Jeffery G. M. & Wolff S. M. 1965. Malaria-induced endotoxin tolerance. Proceedings of the Society for Experimental Biology and Medicine 118: 238-287.
112. Schirmer W. J., Schirmer J. M. & Fry D. E. 1989. Recombinant human tumor necrosis factor produces hemodynamic changes characteristic of sepsis and endotoxemia. Archives of Surgery 124: 445-448.
113. Schofield L., Vivas L., Hackett F., Gerold P., Schwarz R. T. & Tachado S. 1993. Neutralizing monoclonal antibodies to glycosylphosphatidylinositol, the dominant TNF-alpha-Inducing toxin of Plasmodium falciparum - prospects for the immunotherapy of severe malaria. Annals of Tropical Medicine and Parasitology 87: 617-626.
114. Sidey F. M., Wardlaw A. C. & Furman B. I. 1987. Hypoglycaemia and acute stress-induced hyperinsulinaemia in mice infected with Bordetella pertussis or treated with pertussis toxin. Journal of Endocrinology 112: 113-122.
115. Sowunmi A. 1996. Renal function in acute falciparum malaria. Archives of Disease in Childhood 74: 293-298.
116. Spolarics Z., Pekala P. H., Bagby G. J. & Spitzer J. J. 1993. Brief endotoxemia markedly increases expression of GLUT1 glucose transporter in Kupffer, hepatic endothelial and parenchymal cells. Biochemical and Biophysical Research Communications 193: 1211-1215.
117. Spriggs D. R., Sherman M. L., Michie H., Arthur K. A., Imamura K., Wilmore D., Frei E. & Kufe D. W. 1988. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase 1 and pharmacologic study. Journal of the National Cancer Institute 80: 1039-1044.
118. Starnes H. F., Warren R. S., Jeevanandam M., Gabrilove J. L. & Larchian W. 1988. Tumor necrosis factor and the acute metabolic response to tissue injury in man. Journal of Clinical Investigation 82: 1312-1325.
119. Stephens J. M. & Pekala P. H. 1991. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Journal of Biological Chemistry 266: 21839-21845.
120. Stephens J. M. & Pekala P. H. 1992. Transcriptional repression of the C/EBP-alpha and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. Regulations is coordinate and independent of protein synthesis. Journal of Biological Chemistry 267: 13580-13584.
121. Tachado S. D., Gerold P., Mcconville M. J., Baldwin T., Quilici D., Schwarz R. T. & Schofield L. 1996. Glycosylphosphatidylinositol toxin of plasmodium induces nitric oxide synthase expression in macrophages and vascular endothelial cells by a protein tyrosine kinase-dependent and protein kinase c-dependent signaling pathway. Journal of Immunology 156: 1897-1907.
122. Taylor D. J., Whitehead R. J., Evanson J. M., Westmacott D., Feldmann M., Bertfield H., Morris M. A. & Woolley D. E. 1988. Effect of recombinant cytokines on glycolysis and fructose 2,6-bisphosphate in rheumatoid synovial cells in vitro. Biochemical Journal 250: 111-115.
123. Taylor D. W. & Siddiqui W. A. 1978. Effect of falciparum malaria infection on the in vitro mitogen responses of spleen and peripheral blood lymphocytes from owl monkeys. American Journal of Tropical Medicine and Hygiene 27: 738-742.
124. Taylor K., Carr R., Playfair J. H. L. & Saggerson E. D. 1992. Malarial toxic antigens synergistically enhance insulin signalling. FEBS Letters 311: 231-234.
125. Taylor T. E., Molyneux M. E., Wirima J. J., Fletcher K. A. & Morris K. 1988. Blood glucose levels in Malawian children before and during the administration of intravenous quinine for severe falciparum malaria. New England Journal of Medicine 319: 1040-1047.
126. Tiao G., Rafferty J., Ogle C., Fischer J. E. & Hasselgren P. O. 1994. Detrimental effect of nitric oxide synthase inhibition during endotoxemia may be caused by high levels of tumor necrosis factor and interleukin-6. Surgery 116: 332-338.
127. Vallet B., Lund N., Curtis S. E., Kelly D. & Cain S. M. 1994. Gut and muscle tissue PO2 in endotoxemic dogs during shock and resuscitation. Journal of Applied Physiology 76: 793-800.
128. Warrell D. A. 1987. Pathophysiology of severe falciparum malaria in man. Parasitology 94: S53-S76.
129. Warrell D. A., Veall N., Chanthanavich P., Karbwang J., White N. J., Looareesuwan S., Phillips R. E. & Pongpaew P. 1988. Cerebral anaerobic glycolysis and reduced cerebral oxygen transport in human malaria. Lancet ii: 534-538.
130. Weinberg J. B., Misukonis M. A., Shami P. J., Mason S. N., Sauls D. L., Dittman W. A., Wood E. R., Smith G. K., Mcdonald B., Bachus K. E., Haney A. F. & Granger D. L. 1995. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages. Blood 86: 1184-1195.
131. White N. J., Marsh K., Turner R. C., Miller K. D., Berry C. D., Wiliamson D. H. & Brown J. 1987. Hypoglycaemia in African children with severe malaria. Lancet i: 708-711.
132. White N. J., Warrell D. A., Looareesuwan S., Chanthavanich P., Phillips R. E. & Pongpaew P. 1985. Pathophysiological and prognostic significance of cerebrospinal-fluid lactate in cerebral malaria. Lancet i: 776-778.
133. Williamson W. A. & Greenwood B. M. 1978. Impairment of the immune response to vaccination after acute malaria. Lancet i: 1328-1329.
134. Yasmeen D., Laird A. J., Hume D. A. & Weidemann M. J. 1977. Activation of 3-O-methyl-glucose transport in rat thymus lymphocytes by concanavalin A. Temperature and calcium ion dependence and sensitivity to puromycin but not to cycloheximide. Biochimica et Biophysica Acta 500: 89-102.
135. Yki-Jarvinen H., Sammalkorpi K., Koivisto V. A. & Nikkila E. A. 1989. Severity, duration, and mechanisms of insulin resistance during acute infections. Journal of Clinical Endocrinology and Metabolism 69: 317-323.
136. Yong M. Z., Schafer M. K. H., Weihe E., Hai S., Corisdeo S., Zhen F. F., Koprowski H. & Dietzschold B. 1993. Severity of neurological signs and degree of inflammatory lesions in the brains of rats with borna disease correlate with the induction of nitric oxide synthase. Journal of Virology 67: 5786-5791.
137. Zentella A., Manogue K. & Cerami A. 1993. Cachectin/ TNF-mediated lactate production in cultured myocytes is linked to activation of a futile substrate cycle. Cytokine 5: 436-447.
138. Zhang J. & Snyder S. H. 1995. Nitric oxide in the nervous system. Annual Review of Pharmacology and Toxicology 35: 213-233.
139. Ziegler-Heitbrock H. W. L. 1995. Molecular mechanism in tolerance to lipopolysaccharide. Journal of Inflammation 45: 13-26.
140. Zingarelli B., Halushka P. V., Caputi A. P. & Cook J. A. 1995. Increased nitric oxide synthesis during the development of endotoxin tolerance. Shock 3: 102-108.
141. Zingarelli B., Makhlouf M., Halushka P. V., Caputi A. P. & Cook J. A. 1995. Altered macrophage function in tumor necrosis factor alpha-and endotoxin-induced tolerance. Journal of Endotoxin Research 2: 247-254.